Consolidated Statement of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net income (loss)	$ (7,717,648)	$ 774,114
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:
Depreciation	6,772	17,403
FBT employee contribution	(14,377)	(15,586)
Gain on disposal of fixed assets	0	(14,314)
Dispute settlement	7,664,828	0
Share based payment	4,040	0
Interest accrued on shareholder loan	0	59,438
Derivative liability	0	(1,356,424)
Net difference on foreign exchange	10,848	44,599
Convertible notes settlement	0	(57,025)
Other Finance and interest cost	0	149,493
Other selling, general and administrative adjustments	0	5,372
Net changes in operating assets and liabilities
(Increase)/decrease in trade and other receivables	83,820	20,230
(Increase)/decrease in other assets	(9,926)	25,720
Increase/(decrease) in trade and other payables	34,023	(110,405)
Increase/(decrease) in other liabilities	(6,155)	(123,368)
Decrease in deferred tax asset	5,718	1,797
Decrease in tax provision	0	0
Net cash (used in)/provided by operating activities	61,943	(578,956)
Cash flows from investing activities
Payments for property, plant and equipment	0	0
Net cash used in investing activities	0	0
Cash flows from financing activities
Proceeds from Convertible notes	0	83,500
Proceeds from issue of common stock	0	1,200,000
Settlement of Convertible notes	0	(304,000)
Other Finance cost and interest paid	0	(149,493)
Repayment of borrowings	0	(9,737)
Repayment of advances from related entities	(57,042)	(104,358)
Payment of finance lease liabilities	(20,317)	(27,719)
Net cash (used in)/ provide by financing activities	(77,359)	688,193
Net increase in cash and cash equivalents	(15,416)	109,237
Effect of exchange rate changes on cash and cash equivalents	29	27,123
Cash and cash equivalents at the beginning of period	23,245	63,649
Cash and cash equivalents at the end of period	$ 7,858	$ 200,009